Wednesday 22 Oct 2014

TransAtlantic Petroleum Ltd (NYSEMKT:TAT) down by 1.79%, Neuralstem Inc (NYSEMKT:CUR)

New York, NY – (NISMAGAZINE) – 05/29/2013- TransAtlantic Petroleum Ltd (NYSEMKT:TAT) is trading down by 1.79% to close at $0.830. The average true range of the stock is $0.05. The stock price has hit a low of $0.71 in the last 52- weeks and has kissed a high of $1.20 during the same period. At current levels the share price is around 16.38% above its 52-the week’s low and 31.14% below its 52-week’s high. The stock’s 50 days SMA and 200 days SMA are $0.865 and $0.921 respectively and at current levels the stock is trading above the short and below both the long SMA. The relative strength index of the stock is 49.03; the stock is trading flat, neither in the oversold or overbought zone. The stock traded flat during the last 5 trading session wherein it posted a volatility of 4.50% during the same period. The return over a period of one month given by the stock is -1.18%.

TD Securities has lowered its target price on the stock from C$2.25 to C$2.00 and has a “Buy” rating on the stock.

How Should Investors Trade TAT Now? Find out here.

Neuralstem Inc (NYSEMKT:CUR) was trading flat in Tuesday’s session to close at $1.40. The average true range of the stock is $0.10. The stock price has hit a low of $0.42 in the last 52- weeks and has kissed a high of $1.96 during the same period. At current levels the share price is around 230.95% above its 52-the week’s low and 29.08% below its 52-week’s high. The stock’s 50 days SMA and 200 days SMA are $1.20 and $1.11 respectively and at current levels the stock is trading above both the SMAs. The relative strength index of the stock is 59.58; the stock is trading flat, neither in the oversold or overbought zone. The stock has lost about -6.04% in its last 5 trading sessions wherein it posted a volatility of 8.26% during the same period. The return over a period of one month given by the stock is 14.75%.

The company announced that a paper published today has shown that “rats transplanted with its spinal cord-derived human neural stem cells, NSI-566, three days after a spinal cord injury at L3, showed improvement along several measures of motor function and a reduction of spasticity.

Is CUR a solid investment at these levels? Find out here.

About HiddenGemStocks.com

Subscribe for FREE to receive our “50 Stock Trading Rules No Hedge Fund Wants You To Know!” E-Book: http://hiddengemstocks.com/trade.html

HiddenGemStocks.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:

HiddenGemStocks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HiddenGemStocks.com website, for complete risks and disclosures.

Contact:

Gale Wills

info@hiddengemstocks.com

Leave a Comment